Cargando…
Neoantigens: promising targets for cancer therapy
Recent advances in neoantigen research have accelerated the development and regulatory approval of tumor immunotherapies, including cancer vaccines, adoptive cell therapy and antibody-based therapies, especially for solid tumors. Neoantigens are newly formed antigens generated by tumor cells as a re...
Autores principales: | Xie, Na, Shen, Guobo, Gao, Wei, Huang, Zhao, Huang, Canhua, Fu, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816309/ https://www.ncbi.nlm.nih.gov/pubmed/36604431 http://dx.doi.org/10.1038/s41392-022-01270-x |
Ejemplares similares
-
Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer
por: Zheng, Yue, et al.
Publicado: (2022) -
Targeting neoantigens for cancer immunotherapy
por: Zhao, Xuan, et al.
Publicado: (2021) -
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
por: Redwood, Alec J., et al.
Publicado: (2022) -
Cancer neoantigens as potential targets for immunotherapy
por: Ma, Weijie, et al.
Publicado: (2021) -
NAD(+) metabolism: pathophysiologic mechanisms and therapeutic potential
por: Xie, Na, et al.
Publicado: (2020)